Vaccinations

Smaller doses: Pfizer's finances aren't what they were
Covid catchup: The latest data as hospitalizations rise
Pfizer: The pharma giant is putting its Covid cash to work
COVID: Taking stock of COVID's impact, 3 years after Wuhan's lockdown
US vaccine programme: The US vaccination drive has accelerated dramatically
Vaccine scepticism: Anti-vaccine sentiment may be softening as vaccine roll-outs gather pace
Vaccines: Data from the UK adds to the mounting evidence from around the world: the vaccines are working
Vaccine update: How long until we've administered enough?
The vaccination race: Doses are being administered, but which country is out in front?
Vaccine sceptics: With vaccines seemingly just around the corner which countries first need to convince their populations they are safe?
Vaccine effectiveness: How do the COVID-19 vaccines compare to vaccines for other diseases?
We and our partners use cookies and similar technologies (“Cookies”) on our website and in our newsletters for performance, analytical or advertising purposes to ensure you have the best experience on our site and/or interaction with us. To find out more about the use of Cookies, see our Cookie Notice. Please click OK if you consent to our use of Cookies or click Manage my Preferences to manage your Cookie preferences.